What is the "optimal" follow-up schedule for ICD patients?

[1]  H. Katus,et al.  Patient alert in implantable cardioverter defibrillators: toy or tool? , 2004, Journal of the American College of Cardiology.

[2]  Charles R Kerr,et al.  Guidelines for implantable cardioverter defibrillator follow-up in Canada: a consensus statement of the Canadian Working Group on Cardiac Pacing. , 2003, The Canadian journal of cardiology.

[3]  Tim Vaughn,et al.  Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. , 2003, Journal of the American College of Cardiology.

[4]  R. Kerber,et al.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). , 2002, Circulation.

[5]  D. Cannom,et al.  High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[6]  F. Miyake,et al.  Adrenergic stimulation immediately modifies the Ca^ channel gene expression preferentially in the atrium , 2002 .

[7]  J. Ruskin,et al.  Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants. , 2001, The American journal of cardiology.

[8]  G. Breithardt,et al.  Consensus Statement on Indications, Guidelines for Use, and Recommendations for Follow‐up of Implantable Cardioverter Defibrillators , 2001, Pacing and clinical electrophysiology : PACE.

[9]  B. Wilkoff,et al.  Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. , 2001, American heart journal.

[10]  R. Peters,et al.  Sensing Lead Failure in Implantable Defibrillators: , 2000, Journal of cardiovascular electrophysiology.

[11]  A. L'Abbate,et al.  Interaction between coronary artery stenosis and coronary microcirculation in ischemic heart disease , 2000, Zeitschrift für Kardiologie.

[12]  J. Senges,et al.  Komplikationen mit Sonden bei 340 Patienten mit einem implantierbaren Kardioverter/Defibrillator , 1999, Zeitschrift für Kardiologie.

[13]  W. Grimm,et al.  Complications of Third‐Generation Implantable Cardioverter Defibrillator Therapy , 1999, Pacing and clinical electrophysiology : PACE.

[14]  D. Mehta,et al.  Late Complications in Patients with Pectoral Defibrillator Implants with Transvenous Defibrillator Lead Systems: High Incidence of Insulation Breakdown , 1998, Pacing and clinical electrophysiology : PACE.

[15]  S. Hohnloser,et al.  Worldwide Clinical Experience with aDown‐Sized Active Can ImplantableCardioverier Defibrillator in 162 ConsecutivePatients , 1998 .

[16]  M. Rosenqvist,et al.  Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators. , 1998, Circulation.

[17]  J. Neuzner,et al.  Dysfunktionen transvenöser Kardioverter/Defibrillator-Elektrodensysteme: klinische Bedeutung systemintegrierter Diagnose- und Meßfunktionen – Möglichkeiten einer teilautomatisierten Systemkontrolle , 1998, Zeitschrift für Kardiologie.

[18]  M. Stanton,et al.  High failure rate for an epicardial implantable cardioverter-defibrillator lead: implications for long-term follow-up of patients with an implantable cardioverter-defibrillator. , 1998, Journal of the American College of Cardiology.

[19]  H. Vidaillet,et al.  Infections with Nonthoracotomy Implantable Cardioverter Defibrillators: Can These Be Prevented? , 1998, Pacing and clinical electrophysiology : PACE.

[20]  P. D. Henry,et al.  Long-term follow-up of cardioverter-defibrillator implanted under conscious sedation in prepectoral subfascial position. , 1997, Circulation.

[21]  C. Haffajee,et al.  A Multicenter, Randomized Trial Comparing an Active Can Implantable Defibrillator with a Passive Can System , 1997 .

[22]  R. Peters,et al.  Complications Associated with Pectoral Implantation of Cardioverter Defibrillators , 1997, Pacing and clinical electrophysiology : PACE.

[23]  D. Freiman,et al.  Value of radiography in diagnosing complications of cardioverter defibrillators implanted without thoracotomy in 437 patients. , 1997, AJR. American journal of roentgenology.

[24]  G. Steinbeck,et al.  Failures of epicardial and transvenous leads for implantable cardioverter defibrillators. , 1995, American heart journal.

[25]  B. Lüderitz,et al.  Incidence of ICD Lead Related Complications During Long‐Term Follow‐Up: Comparison of Epicardial and Endocardial Electrode Systems , 1995, Pacing and clinical electrophysiology : PACE.

[26]  F. Marchlinski,et al.  Postoperative lead-related complications in patients with nonthoracotomy defibrillation lead systems. , 1995, Journal of the American College of Cardiology.

[27]  P. Kudenchuk,et al.  Mechanical complications after implantation of multiple-lead nonthoracotomy defibrillator systems: implications for management and future system design. , 1995, American heart journal.

[28]  J. Ruskin,et al.  Limitations and late complications of third-generation automatic cardioverter-defibrillators. , 1995, Circulation.

[29]  B. Wilkoff,et al.  Low Incidence of Lead Related Complications Associated with Nonthoracotomy Implantable Cardioverter Defibrillator Systems , 1995, Pacing and clinical electrophysiology : PACE.

[30]  F. Morady,et al.  Incidence, presentation, diagnosis, and management of malfunctioning implantable cardioverter-defibrillator rate-sensing leads. , 1994, American heart journal.

[31]  J. Langberg,et al.  Implantation by Electrophysiologists of 100 Consecutive Cardioverter Defibrillators With Nonthoracotomy Lead Systems , 1994, Circulation.

[32]  K. Ellenbogen,et al.  Sensing/pacing lead complications with a newer generation implantable cardioverter-defibrillator: worldwide experience from the Guardian ATP 4210 clinical trial. , 1994, Journal of the American College of Cardiology.

[33]  George A. Johnson,et al.  A Simplified, Single‐Lead Unipolar Transvenous Cardioversion‐Defibrillation System , 1993, Circulation.

[34]  F. Marchlinski,et al.  Complications of Implantable Cardioverter Defibrillator Therapy: Follow‐Up of 241 Patients , 1993, Pacing and clinical electrophysiology : PACE.

[35]  P E Oyer,et al.  Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. , 1985, Circulation.